Page last updated: 2024-10-28

hydroxyzine and Acantholytic Dyskeratotic Epidermal Nevi

hydroxyzine has been researched along with Acantholytic Dyskeratotic Epidermal Nevi in 1 studies

Hydroxyzine: A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
hydroxyzine : A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lokesh, V1
Lakshmikantha, A1
Kannan, S1

Other Studies

1 other study available for hydroxyzine and Acantholytic Dyskeratotic Epidermal Nevi

ArticleYear
Kyrle's disease: a cutaneous manifestation of diabetes mellitus.
    BMJ case reports, 2017, Nov-01, Volume: 2017

    Topics: Antipruritics; Biopsy; Darier Disease; Diabetes Mellitus, Type 2; Diagnosis, Differential; Female; H

2017